Transforming health with partnerships
LIGHTHOUSE LIFE SCIENCE invites you to learn about our model for partnerships and become part of a global community dedicated to promoting equity in health through cross-sector partnerships.
Let’s build trust and drive positive change together.
WHAT CAN WE LEARN FROM LIGHTHOUSE LIFE SCIENCE ?
Denmark’s life science industry serves as a model for how innovation, collaboration, and trust can drive transformative change. By combining the strengths of public and private partnerships, the sector is able to achieve measurable results that benefit not only the economy but also society as a whole.
SHARING OUR EXPERIENCES
Diana Arsovic Nielsen is looking forward to sharing experiences from Danish Life Science and Lighthouse Life Science with partners from all over the world at Tour de Health and in the following community.
Meet Diana Arsovic Nielsen, CEO, Danish Life Science Cluster.
SOLUTIONS CREATED I PARTNERSHIPS ARE MORE LIKELY TO BE IMPLEMENTED
It takes an open heart to join a partnership and everybody must be prepared to learn new ways.
If you’re honest about the mistakes you have made the others don’t have to make the same mistakes.
Meet Carolyn Bennett, Canadian Ambassador to the Kingdom of Denmark.
CREATING LASTING HEALTH AND SOCIETAL IMPACT
At the heart of Denmark’s life science industry lies the belief that innovation is not merely about financial gain—it’s about creating lasting health and societal impact. By focusing on breakthroughs in biotechnology, pharmaceuticals, and medical technology, the sector has come together to address some of the most pressing global challenges, including aging populations, chronic diseases, and environmental sustainability. This industry isn’t just producing new products and treatments; it’s generating solutions that enhance quality of life and contribute to the greater good.
Central to this innovation is the collaboration between public institutions, private companies, and research organizations. Denmark’s life science sector is built on a foundation of trust and partnership, where stakeholders share a common vision of using their collective knowledge and resources to create a better future. This collaboration ensures that new technologies and treatments are not only developed but also efficiently brought to market and implemented on a large scale.
PARTNERSHIPS MUST BE BUILT OM TRUST
Trust is essential, because partnerships are not a competition!
If we are to create sustainable solutions with lasting effects, we must stand together – and strong partnerships are built on trust.
Meet Thomas Alslev, Senior Vice President, Novo Nordisk Foundation.
A FOUNDATION OF TRUST AND PARTNERSHIPS
Central to innovation is the collaboration between public institutions, private companies, and research organizations. Denmark’s life science sector is built on a foundation of trust and partnership, where stakeholders share a common vision of using their collective knowledge and resources to create a better future. This collaboration ensures that new technologies and treatments are not only developed but also efficiently brought to market and implemented on a large scale.
PARTNERSHIPS CAN BRING GLOBAL ATTENTION TO HOSPITALS
We need to very honest and transparent when we form partnerships. We can only create the best results if we can define the true unmet medical need.
Julie Brooker, Country Director, Denmark, Johnson & Johnson
I CAN'T DO RESEARCH ALL BY MY SELF
– I need collaborations with other researchers, and the results will be even stronger when we collaborate with business, the public sector and civil society.
Maria Kristiansen has researched partnerships and OPI under Erhvervsfyrtårn Life Science.
Her team published the evaluation ’10 recommendations – how sustainable partnerships can create new effective solutions’ – find it here.
Meet Maria Kristiansen, professor at the University of Copenhagen.
LIGHTHOUSE LIFE SCIENCE IS AN ACTIVE TOOL FOR COLLABORATION
Denmark’s life science sector is not just about innovation—it’s about achieving measurable results that make a real difference in people’s lives. The sector operates with a clear focus on both short-term and long-term outcomes.
In the short term, the emphasis is on achieving results through pilot projects and a growth platform. These projects are designed to secure funding, disseminate findings to private funds, and leverage methodologies to provide recommendations to public actors. By rapidly piloting new ideas and securing investment, Denmark’s life science sector can quickly bring innovative solutions to market.
LET'S TAKE COLLABORATION TO A NEW LEVEL
When we enter into a partnership we need to define the long term effects.
We have collaborated across the public and private sector for many years. Now we must take the collaboration to a new level and talk about long-term binding partnerships.
Meet Martin Magelund Rasmussen, Debuty CEO, Rigshospitalet
HOW DENMARK REMAINS A GLOBAL LEADER IN LIFE SCIENCE INNOVATION
In the long term, the focus shifts to scaling successful projects and fostering new business opportunities. The results and methodologies developed in pilot projects are used on a larger scale, ensuring that the impact is felt across a broader spectrum of industries and communities. This long-term approach not only drives economic growth but also ensures that Denmark remains a global leader in life science innovation.
Key Performance Indicators (KPIs) here play a crucial role in measuring the success of Denmark’s life science sector. KPIs are used to track progress in various areas, including existing KPI’s on health and well-being, growth, and future KPI’s on environmental sustainability, social responsibility, and governance
